Primary immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2008–2017

References

• Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS. Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med. 2009;7(1):47. doi:10.1186/1741-7015-7-47.
   PubMedGoogle Scholar
• Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meer HC, Baker CJ, Messonnier NE. Centers for Disease Control and Prevention (CDC): prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1–28.
   PubMed Web of Science ®Google Scholar
• Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J, Fermon F, Klugman KP, Ramsay M, Sow S. Global epidemiology of invasive meningococcal disease[J]. Popul Health Metr. 2013;11(1):17. doi:10.1186/1478-7954-11-17.
   PubMed Web of Science ®Google Scholar
• Stephens DS. Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine. 2009;27(Suppl. 2):B71–77. doi:10.1016/j.vaccine.2009.04.070.
   PubMed Web of Science ®Google Scholar
• Vyse A, Wolter JM, Chen J, NG T, SORIANO-GABARRO M. Meningococcal disease in Asia: an under-recognized public health burden. Epidemiol Infect. 2011;139(7):967⁃985. doi:10.1017/S0950268811000574.
   PubMed Web of Science ®Google Scholar
• Shao Z. Epidemiology and switching of meningococcal disease in China[J]. Chin J Prev Med. 2013;47:891–93.
   Google Scholar
• Experts′ consensus on immunization with meningococcal vaccines in China[J]. Chin J Prev Med. 2019;53(2):141–45.
   Google Scholar
• Liu WT, Li JH, Ning GJ, Wu D, Yin ZD, Li YX. Epidemiological characteristics of Meningococcal Meningitis in China, 2012-2014[J]. Chin J Vaccine Immun. 2016;2:149⁃152,179.
   Google Scholar
• Plotkin SA, Orenstein WA, Offit PA. Vaccines [M]. 7th ed. Philadelphia(PA): Elsevier; 2018. p. 622.
   Google Scholar
• Cui J, Cao L, Zheng JS, Cao LS, Yuan P, Wang M, Xiao QY, Wang HQ. Analysis of reported coverage rates of vaccines in national immunization program in china,2014[J]. Chin J Vaccine Immun. 2016;22(1):34–40.
   Google Scholar
• Deng X, Yao PP, He HQ, Yan R, Tang XW, Zhou Y, Fu J, Xie SY. Epidemiological characteristics of meningococcal meningitis and changing trend of serogroups of Neisseria meningitidis in Zhejiang,2006-2017[J]. Disease Surveillance. 2018;33(7):547–51.
   Google Scholar
• Yang  RC, Zhong G, Gan M, Li S, Du JF, Huang Y, Chen SY, Dong AH. Analysis of category vaccine application status in Guangxi Zhuang autonomous region,2010 to 2016[J]. Chin Primary Health Care. 2018;32(7):34–35,38.
   Google Scholar
• Li JH, Li YX, Wu D, Ning GJ, Shao ZJ, Yin Zd. Epidemiological characteristics of meningococcal meningitis and switching trend of serogroups of neisseria meningitidis in China,2006-2014[J]. Chin J Vaccine Immun. 2015;21(5):481–85.
   Google Scholar
• Wen HR, Liao Z, Zhang YX, Peng SH, Xu B. Discussion on immune strategy of meningococcal vaccines[j]. Occup and Health. 2016;32(19):2729–32.
   Google Scholar
• Qin CZ, Wang HJ, Tao H, Ma FB, Ze WY. Study on immunogenicity between different doses of group A/C meningococcal polysaccharide conjugate vaccine[j]. Chin J Vaccine Immun. 2010;5:462–65.
   Google Scholar
• Pan JR, Chen HH, Li SJ, Luo SY, He HQ, Chen EF. Immunogenicity of group a and group c meningococcal conjugate vaccine after primary immunization in children aged 6 months[J]. Chin J Vaccine Immun. 2015;5:511–14.
   Google Scholar
• Southern J, Crowley-Luke A, Borrow R. Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2,3 and 4months of age with acellular pertussis-containing DTP/Hib vaccine[J]. Vaccine. 2006;24(2):215–19. doi:10.1016/j.vaccine.2005.07.060.
   PubMed Web of Science ®Google Scholar
• Javadekar B, Ghosh A, Kompithra RZ, Awasthi S, Perminova O, Romanenko V, Rodnikova V, Kharit S, Thollot Y, Bosch-Castells V, et al. Safety and immunogenicity of two doses of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in Indian and Russian children aged 9 to 17 months[J]. Indian Pediatr. 2018;55(12):1050–55. doi:10.1007/s13312-018-1440-z.
   PubMed Web of Science ®Google Scholar
• Hansen J, Zhang L, Eaton A, Baxter R, Robertson CA, Decker MD, Greenberg DP, Bassily E, Klein NP. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children. Vaccine. 2018;36(16):2133–38. doi:10.1016/j.vaccine.2018.02.107.
   PubMed Web of Science ®Google Scholar
• Ning X, Li JH, Li YX, Yin ZD, Ze WY, Wang XX, Wang HQ, Li L. Feasibility of meningococcal polysaccharide vaccines integrated into Chinese NIP and the foundation of immunization schedule[J]. Chin J Vaccine Immun. 2008;14(2):171–75.
   Google Scholar
• Chai ZK, Li J, Shao ZJ, Li FX, Diao LD, Li L, Yin JD. Minutes of the meningococcal meningitis surveillance and immunization prevention seminar[J]. Modern Prev Med. 2015;16(12):901–03.
   Google Scholar
• Zhang WY, Zhang YJ, Liu SN, Zeng Z, Xu Q, Li Z, Xiao ZK, Song LZ. Analysis of the current status of category vaccination among children aged 1-5 in Shangdong province[J]. Modern Prev Med. 2016;43(10):1886–89.
   Google Scholar
• Chang J, Hou ZY, Yue DH, Wu Q, Fang H, Meng QY. Factors related to self-paid vaccination and its related factors among children aged 0-3years in China[J]. Chin J Public Health. 2014;30(5):579–82.
   Google Scholar
• Qingchun L. Investigation of cognitive status of residents in varicella vaccine in Linqing[J]. Henan J Prev Med. 2016;7:524–525,528.
   Google Scholar
• Che XR, Xu EP, Pan JR, Liu Y, Xi Y, Peng J, Zhu JH, Fang T, Qian CY. Observation on the adverse effects following immunization of group A meningococcal polysaccharide vaccine and group A and group C meningococcal conjugate vaccine[J]. Zhejiang Prev Med. 2013;25(11):51–53.
   Google Scholar
• Chinese preventive medicine association. Efficacy, safety, and cost-effectiveness of meningococcal vaccines[J]. Chin J Vaccine Immun. 2019;25(1):102–108,114.
   Google Scholar